Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis

por Bi, Yan-Ling, Mi, Pei-Yan, Zhao, Shi-Jun, Pan, Heng-Ming, Li, Hui-Juan, Liu, Fei, Shao, Lu-Rong, Zhang, Hui-Fang, Zhang, Pu, Jiang, Shi-Liang
Publicado 2017